SE441745B - Pyridylaminotriazolderivat och famaceutisk beredning innehallande dessa - Google Patents

Pyridylaminotriazolderivat och famaceutisk beredning innehallande dessa

Info

Publication number
SE441745B
SE441745B SE8004498A SE8004498A SE441745B SE 441745 B SE441745 B SE 441745B SE 8004498 A SE8004498 A SE 8004498A SE 8004498 A SE8004498 A SE 8004498A SE 441745 B SE441745 B SE 441745B
Authority
SE
Sweden
Prior art keywords
amino
triazole
pyridyl
reaction
pure
Prior art date
Application number
SE8004498A
Other languages
English (en)
Swedish (sv)
Other versions
SE8004498L (sv
Inventor
C A Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE8004498L publication Critical patent/SE8004498L/xx
Publication of SE441745B publication Critical patent/SE441745B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86Hydrazides; Thio or imino analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8004498A 1979-06-18 1980-06-17 Pyridylaminotriazolderivat och famaceutisk beredning innehallande dessa SE441745B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/049,737 US4276297A (en) 1979-06-18 1979-06-18 Pyridylaminotriazole therapeutic agents

Publications (2)

Publication Number Publication Date
SE8004498L SE8004498L (sv) 1980-12-19
SE441745B true SE441745B (sv) 1985-11-04

Family

ID=21961428

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8004498A SE441745B (sv) 1979-06-18 1980-06-17 Pyridylaminotriazolderivat och famaceutisk beredning innehallande dessa

Country Status (24)

Country Link
US (1) US4276297A (it)
JP (1) JPS565477A (it)
KR (2) KR840002173B1 (it)
AR (2) AR225766A1 (it)
AT (2) AT375655B (it)
BE (1) BE883859A (it)
CA (1) CA1140133A (it)
CH (1) CH644375A5 (it)
DE (1) DE3022302C2 (it)
DK (1) DK258180A (it)
ES (2) ES8105313A1 (it)
FI (1) FI69842C (it)
FR (1) FR2459241A1 (it)
GB (1) GB2053910B (it)
GR (1) GR68731B (it)
IE (1) IE49913B1 (it)
IL (1) IL60332A (it)
IT (1) IT1140993B (it)
LU (1) LU82527A1 (it)
NL (1) NL182641C (it)
PH (1) PH16875A (it)
PT (1) PT71399A (it)
SE (1) SE441745B (it)
YU (2) YU41717B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR230994A1 (es) * 1981-08-31 1984-08-31 Pfizer Procedimiento para preparar compuesto de 3'-substituido-5'-(2-amino-4-piridil)-1',2',4'-triazol
JP2518515Y2 (ja) * 1993-09-22 1996-11-27 茂郎 槇島 水虫用医療包帯
US9440953B2 (en) * 2014-12-19 2016-09-13 OncoArendi Therapeutics Sp. z o.o. Substituted amino triazoles useful as acidic mammalian chitinase inhibitors
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1925654U (de) 1965-07-23 1965-10-21 Alfons Mann Zusatzeinrichtung fuer vergaser an benzinmotoren zur steigerung der motorenleistung.
CH521419A (de) * 1968-03-01 1972-04-15 Ciba Geigy Ag Verfahren zur Herstellung neuer Azofarbstoffe
GB1264798A (it) 1968-07-10 1972-02-23
US3647814A (en) * 1969-07-03 1972-03-07 Rohm & Haas Method for preparing 4-substituted-1 2 4-triazoles
NL7112372A (it) * 1970-09-25 1972-03-28
NL7112373A (it) * 1970-09-25 1972-03-28
GB1403866A (en) * 1971-12-06 1975-08-28 Wyeth John & Brother Ltd Derivatives of 3-amino-1,2,4-triazoles
US3879404A (en) * 1972-07-07 1975-04-22 John J Baldwin Certain 5-(pyridyl)-3(phenyl)-1,2,4-triazoles
US3873563A (en) * 1972-09-29 1975-03-25 Sakai Chemical Industry Co Method for manufacturing 4-amino-1,2,4-triazoles
US3928361A (en) * 1973-05-21 1975-12-23 Merck & Co Inc 1-(Sulfamoylphenylalkyl)-3,5-dipyridyl-1,2,4 triazoles
US3984558A (en) * 1973-05-21 1976-10-05 Merck & Co., Inc. 1,3,5-Trisubstituted-1,2,4-triazole compounds used as bronchodilators

Also Published As

Publication number Publication date
AR225766A1 (es) 1982-04-30
SE8004498L (sv) 1980-12-19
IL60332A0 (en) 1980-09-16
CH644375A5 (fr) 1984-07-31
FR2459241A1 (fr) 1981-01-09
CA1140133A (en) 1983-01-25
ES498821A0 (es) 1981-12-01
NL182641B (nl) 1987-11-16
KR840002173B1 (ko) 1984-11-26
IL60332A (en) 1983-09-30
IT1140993B (it) 1986-10-10
NL182641C (nl) 1988-04-18
IE49913B1 (en) 1986-01-08
IT8022825A0 (it) 1980-06-17
KR840002172B1 (ko) 1984-11-26
IE801250L (en) 1980-12-18
ATA307583A (de) 1984-01-15
AT375656B (de) 1984-08-27
FR2459241B1 (it) 1983-06-17
DK258180A (da) 1980-12-19
YU41536B (en) 1987-08-31
GB2053910B (en) 1983-04-20
FI69842C (fi) 1986-05-26
KR840004687A (ko) 1984-10-22
ES492522A0 (es) 1981-06-01
DE3022302C2 (de) 1984-03-01
FI801929A (fi) 1980-12-19
YU263382A (en) 1983-04-30
BE883859A (fr) 1980-12-17
GB2053910A (en) 1981-02-11
YU158780A (en) 1983-04-30
DE3022302A1 (de) 1981-01-08
FI69842B (fi) 1985-12-31
LU82527A1 (fr) 1981-02-03
ATA319280A (de) 1984-01-15
KR830002756A (ko) 1983-05-30
AR227436A1 (es) 1982-10-29
YU41717B (en) 1987-12-31
JPS565477A (en) 1981-01-20
ES8201155A1 (es) 1981-12-01
PH16875A (en) 1984-04-02
US4276297A (en) 1981-06-30
ES8105313A1 (es) 1981-06-01
PT71399A (en) 1980-07-01
JPS617426B2 (it) 1986-03-06
AT375655B (de) 1984-08-27
NL8003496A (nl) 1980-12-22
GR68731B (it) 1982-02-10

Similar Documents

Publication Publication Date Title
KR100371297B1 (ko) 치환된티아졸리딘디온유도체
DE69221059T2 (de) Indolderivate und antiulcerose Zubereitungen
JP3751942B2 (ja) リスペリドンの調製
JPH04103585A (ja) ピロリジン環を有する化合物
AU2005207925B2 (en) Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase Type 1
US4305944A (en) N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones
WO1986001510A1 (en) Tricyclic oxindole antiinflammatory agents
KR850001226B1 (ko) 이미다졸릴 피리딘치료제의 제조방법
SE441745B (sv) Pyridylaminotriazolderivat och famaceutisk beredning innehallande dessa
KR900006722B1 (ko) 항불안제
US4090020A (en) Thienothiazine derivatives
EP0074229B1 (en) Triazole gastric anti-secretory agents
US4105764A (en) 4,5-Dihydro-5-oxopyrazolo[1,5-A]quinazoline-3-carboxamides
JPH0764844B2 (ja) ピリダジノピロロイソキノリン誘導体
US4175085A (en) Thienothiazine derivatives
EP0157656A2 (en) Process and intermediates for the preparation of aryl substituded pyrido [1,4] benzodiazepines
CA1123852A (en) Cyclododecane derivatives and a process for the preparation thereof
HU188742B (en) Process for producing substituted 3,4-diamni-1,2,5-thiadiazoles and pharmaceutical compositions of hystamine-h2-receptor antagonistic aczivity containing them as active agents
SE445453B (sv) 3,5-difenyl-1h-1,2,4-triazolderivat, forfarande for framstellning derav samt antireproduktiv, farmaceutisk komposition innehallande nemnda derivat
DK141530B (da) Analogifremgangsmaade til fremstilling af lactamer
NZ205891A (en) 4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxides and pharmaceutical compositions
US4293703A (en) Imidazole or imidazoline substituted ureas
SE463716B (sv) 2-halonicergolinderivat, foerfarande foer framstaellning av detta och en farmaceutisk beredning
NO833147L (no) Polymorfe forbindelsr, samt fremgangsmaate for fremstilling av slike.
DK142847B (da) Analogifremgangsmåde til fremstilling af N-2,6-dichlorphenyl-2-aminopyrimidin.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8004498-5

Effective date: 19900620

Format of ref document f/p: F